InvestorsHub Logo

sokol

07/23/19 8:39 PM

#203023 RE: Biostockclub #203018

Man, that answer by Michael, is a good example of a bureaucratic non-answer. Biogen, has been successful overall, but it is clearly failing in its struggle when it comes to treating AD. It may very likely be that Biogen is saving face while pursing another AD strategy through and with the help of Eisai as its partner in crime. Actually, given what has transpired, that is not a good strategy for Biogen.

nidan7500

07/24/19 6:48 AM

#203040 RE: Biostockclub #203018

Biostockclub, thank you for this information and for your insight-interpretation. Looks like you nailed it. They do not sound optimistic. We have a family friend in the BAN2401 trial. Not sounding pumped at all.

On the ++ side it is starting to look more like....any trial still alive is a positive sign indeed.

Thanks again.